V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 280003361 | 280002517 | 1.7 | 58.6 | Curative (C) | 2017-10-21 | 2017-10-21 | Cetuximab + Radiotherapy Load | 02 | Y | 280025446 | CETUXIMAB + RT |
| 280003362 | 280002518 | 1.77 | 98.2 | Curative (C) | 2016-01-18 | 2016-02-15 | Cetuximab + Radiotherapy Maint | 02 | N | 280025447 | CETUXIMAB + RT |
| 280003364 | 280002520 | 1.59 | 93 | Curative (C) | 2014-04-24 | 2014-05-11 | Cisplatin + Docetaxel +Fluorouracil | N | N | 280025450 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003365 | 280002521 | 1.74 | 123 | null | 2017-05-02 | 2017-05-13 | CETUXIMAB + RT | 2 | N | 280025451 | CETUXIMAB + RT |
| 280003366 | 280002522 | 1.8 | 74.2 | Curative (C) | 2015-11-22 | 2015-11-27 | CETUXIMAB + RT | N | Y | 280025452 | CETUXIMAB + RT |
| 280003367 | 280002522 | 1.75 | 97.5 | null | 2013-05-19 | 2013-06-11 | Cisplatin + Docetaxel +Fluorouracil | N | N | 280025452 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003368 | 280002523 | 1.85 | 98 | Neo-adjuvant (N) | 2017-10-31 | 2017-11-19 | CISPLATIN + FLUOROURACIL | N | N | 280025454 | CISPLATIN + FLUOROURACIL |
| 280003369 | 280002523 | 1.77 | 88.4 | null | 2016-08-06 | 2016-08-15 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 280025454 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003370 | 280002524 | 1.77 | 34.6 | Neo-adjuvant (N) | null | 2013-05-23 | Cisplatin +Fluorouracil (3 wk) | 02 | N | 280025456 | CISPLATIN + FLUOROURACIL |
| 280003371 | 280002525 | null | 96.6 | Neo-adjuvant (N) | 2013-07-17 | 2013-07-20 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 280025457 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003372 | 280002526 | 1.58 | 91 | Neo-adjuvant (N) | 2017-05-03 | 2017-05-16 | Cisplatin + Docetaxel +Fluorouracil | 02 | null | 280025459 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003373 | 280007290 | 168 | 91 | null | 2016-01-07 | 2016-01-27 | CETUXIMAB + RT | null | null | 280025462 | CETUXIMAB + RT |
| 280003374 | 280007290 | 1.6 | 52.1 | Curative (C) | 2014-03-25 | 2014-03-28 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 280025462 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003375 | 280007290 | 1.71 | 93.3 | Curative (C) | 2015-03-15 | 2015-03-15 | Cisplatin + Docetaxel +Fluorouracil | 2 | null | 280025462 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003376 | 280011529 | 1.65 | 108 | Neo-adjuvant (N) | 2015-07-21 | 2015-07-27 | Cisplatin + Docetaxel +Fluorouracil | N | N | 280025468 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003377 | 280002527 | 1.74 | 62 | Neo-adjuvant (N) | 2016-01-04 | 2016-01-04 | Cisplatin + Docetaxel +Fluorouracil | 02 | null | 280025469 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003378 | 280002527 | 1.7 | 123 | Curative (C) | 2016-12-12 | 2017-12-12 | Cisplatin +Fluorouracil (3 wk) | 2 | N | 280025469 | CISPLATIN + FLUOROURACIL |
| 280003379 | 280002528 | 1.71 | 95.3 | Neo-adjuvant (N) | 2016-05-03 | 2016-05-29 | Cisplatin + Docetaxel +Fluorouracil | 2 | null | 280025472 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003380 | 280002528 | 0 | 77 | null | 2017-03-04 | 2017-03-21 | Cetuximab + Radiotherapy Load | N | Y | 280025472 | CETUXIMAB + RT |
| 280003381 | 280002529 | 1.78 | 77 | Neo-adjuvant (N) | 2013-08-02 | 2013-08-08 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 280025479 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003382 | 280002529 | 1.67 | 91 | Neo-adjuvant (N) | 2017-06-29 | 2017-07-18 | Cisplatin + Docetaxel +Fluorouracil | N | Y | 280025479 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003383 | 280002529 | 1.76 | 67.7 | Neo-adjuvant (N) | 2015-06-21 | 2015-06-27 | Cisplatin +Fluorouracil (3 wk) | 2 | N | 280025479 | CISPLATIN + FLUOROURACIL |
| 280003384 | 280002530 | 1.65 | 75.7 | Neo-adjuvant (N) | 2018-09-06 | 2018-10-02 | DOXORUBICIN + IFOSFAMIDE | 02 | N | 280025486 | DOXORUBICIN + IFOSFAMIDE |
| 280003385 | 280007294 | 1.6 | 86.3 | Neo-adjuvant (N) | 2017-04-08 | 2017-04-28 | Doxorubicin + Ifosfamide | 02 | N | 280025489 | DOXORUBICIN + IFOSFAMIDE |
| 280003386 | 280002531 | 1.82 | 62.4 | Neo-adjuvant (N) | 2017-11-27 | 2017-12-16 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 02 | N | 280025490 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003387 | 280002532 | 1.73 | 92 | null | 2017-10-23 | 2017-10-23 | CISPLATIN + FLUOROURACIL | 02 | null | 280025491 | CISPLATIN + FLUOROURACIL |
| 280003388 | 280002533 | null | null | Curative (C) | 2013-11-25 | 2013-12-22 | CETUXIMAB + RT | 02 | Y | 280025492 | CETUXIMAB + RT |
| 280003389 | 280002534 | 1.8 | 94.2 | null | 2017-03-20 | 2017-03-31 | Cisplatin + Docetaxel +Fluorouracil | 02 | N | 280025498 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003390 | 280002535 | 1.75 | 50.6 | Neo-adjuvant (N) | 2015-05-11 | 2015-05-14 | Cisplatin + Docetaxel +Fluorouracil | N | N | 280025499 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003391 | 280002536 | 1.67 | 74.9 | Disease modification (D) | 2015-03-16 | 2015-03-16 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 02 | N | 280025500 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003392 | 280002537 | 1.81 | 98.9 | null | 2017-10-21 | 2017-12-07 | Doxorubicin + Ifosfamide | N | Y | 280025502 | DOXORUBICIN + IFOSFAMIDE |
| 280003393 | 280002537 | 1.65 | 69.2 | Curative (C) | null | 2015-08-19 | Doxorubicin + Ifosfamide | N | N | 280025502 | DOXORUBICIN + IFOSFAMIDE |
| 280003394 | 280002538 | 1.64 | 74 | Neo-adjuvant (N) | null | 2016-08-25 | CISPLATIN + DOCETAXEL + FLUOROURACIL | null | null | 280025504 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003395 | 280002539 | 1.83 | null | Neo-adjuvant (N) | 2015-04-05 | 2015-04-08 | Cisplatin + Docetaxel +Fluorouracil | null | null | 280025505 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003396 | 280002540 | 1.56 | 80 | null | 2015-04-22 | 2015-04-29 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 01 | N | 280025507 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003397 | 280002541 | 1.75 | 67.35 | null | 2014-06-14 | 2014-06-26 | CISPLATIN + FLUOROURACIL | N | N | 280025508 | CISPLATIN + FLUOROURACIL |
| 280003398 | 280002542 | 1.75 | 73 | null | 2013-09-07 | 2013-09-08 | CETUXIMAB + RT | N | Y | 280025509 | CETUXIMAB + RT |
| 280003399 | 280002543 | 1.69 | 88.9 | Neo-adjuvant (N) | 2016-05-14 | 2016-05-23 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 02 | null | 280025510 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003400 | 280002544 | 1.75 | 44.5 | Neo-adjuvant (N) | 2016-07-23 | 2016-07-27 | Doxorubicin + Ifosfamide | N | N | 280025511 | DOXORUBICIN + IFOSFAMIDE |
| 280003401 | 280002545 | 1.78 | 72.9 | null | 2016-07-13 | 2016-08-10 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 280025512 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003402 | 280002546 | 1.54 | 88.65 | Neo-adjuvant (N) | 2016-06-14 | 2016-06-16 | Cisplatin + Docetaxel +Fluorouracil | N | N | 280025514 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003403 | 280002547 | 1.68 | 66.4 | Curative (C) | 2015-06-03 | 2015-06-08 | Cisplatin + Docetaxel +Fluorouracil | 02 | N | 280025515 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003404 | 280002547 | 1.62 | 79 | null | 2016-07-25 | 2016-07-26 | Cisplatin + Docetaxel +Fluorouracil | N | N | 280025515 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003405 | 280002547 | 1.78 | 95.5 | Neo-adjuvant (N) | 2016-09-11 | 2016-10-01 | Cisplatin + Docetaxel +Fluorouracil | N | N | 280025515 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003406 | 280002548 | 1.65 | 68.1 | null | 2016-09-21 | 2016-09-21 | CETUXIMAB + RT | 02 | N | 280025519 | CETUXIMAB + RT |
| 280003407 | 280002549 | 1.8 | 84.2 | 2 | 2017-01-17 | 2017-01-20 | CISPLATIN + FLUOROURACIL | N | N | 280025521 | CISPLATIN + FLUOROURACIL |
| 280003408 | 280002550 | 1.5 | 90.5 | Disease modification (D) | 2016-02-02 | 2016-02-11 | Doxorubicin + Ifosfamide | N | N | 280025522 | DOXORUBICIN + IFOSFAMIDE |
| 280003409 | 280007297 | 1.53 | 61.6 | null | 2017-11-29 | 2017-12-21 | DOXORUBICIN + IFOSFAMIDE | N | N | 280025523 | DOXORUBICIN + IFOSFAMIDE |
| 280003410 | 280002551 | 1.82 | 85 | Curative (C) | 2015-01-10 | 2015-01-14 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 280025524 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003411 | 280002552 | 1.8 | 89.8 | Neo-adjuvant (N) | 2014-01-20 | 2014-01-24 | Cisplatin +Fluorouracil (3 wk) | 02 | null | 280025525 | CISPLATIN + FLUOROURACIL |